India IVD Raw Materials Market Size, Share & Trends Analysis Report By Product (Antibody, Antigens, Proteins, Enzymes, Biological Buffers, Substrates, Others), By Technology (Molecular Diagnostics, Clinical Chemistry, Immunochemistry, Others), By End User (Diagnostic Laboratories, Pharmaceutical & Biotechnological Companies, Others) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 10, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR6258DR | Pages: 80

Market Segmentation

  1. India IVD Raw Materials Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Antibody
    2. Antigens
    3. Proteins
    4. Enzymes
    5. Biological Buffers
    6. Substrates
    7. Others
  2. India IVD Raw Materials Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Molecular Diagnostics
    2. Clinical Chemistry
    3. Immunochemistry
    4. Others
  3. India IVD Raw Materials Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Diagnostic Laboratories
    2. Pharmaceutical & Biotechnological Companies
    3. Others
  4. Regional India IVD Raw Materials Market
    1. North America
      1. North America India IVD Raw Materials Market By Product 2022-2034 (USD MILLION/ Units)
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
      2. North America India IVD Raw Materials Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Clinical Chemistry
        3. Immunochemistry
        4. Others
      3. North America India IVD Raw Materials Market By End User 2022-2034 (USD MILLION/ Units)
        1. Diagnostic Laboratories
        2. Pharmaceutical & Biotechnological Companies
        3. Others
      4. U.S.
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      5. Canada
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
    2. Europe
      1. Europe India IVD Raw Materials Market By Product 2022-2034 (USD MILLION/ Units)
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
      2. Europe India IVD Raw Materials Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Clinical Chemistry
        3. Immunochemistry
        4. Others
      3. Europe India IVD Raw Materials Market By End User 2022-2034 (USD MILLION/ Units)
        1. Diagnostic Laboratories
        2. Pharmaceutical & Biotechnological Companies
        3. Others
      4. U.K.
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      5. Germany
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      6. France
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      7. Spain
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      8. Italy
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      9. Russia
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      10. Nordic
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      11. Benelux
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      12. Rest of Europe
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
    3. APAC
      1. APAC India IVD Raw Materials Market By Product 2022-2034 (USD MILLION/ Units)
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
      2. APAC India IVD Raw Materials Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Clinical Chemistry
        3. Immunochemistry
        4. Others
      3. APAC India IVD Raw Materials Market By End User 2022-2034 (USD MILLION/ Units)
        1. Diagnostic Laboratories
        2. Pharmaceutical & Biotechnological Companies
        3. Others
      4. China
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      5. Korea
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      6. Japan
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      7. India
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      8. Australia
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      9. Taiwan
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      10. South East Asia
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      11. Rest of Asia-Pacific
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
    4. Middle East and Africa
      1. Middle East and Africa India IVD Raw Materials Market By Product 2022-2034 (USD MILLION/ Units)
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
      2. Middle East and Africa India IVD Raw Materials Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Clinical Chemistry
        3. Immunochemistry
        4. Others
      3. Middle East and Africa India IVD Raw Materials Market By End User 2022-2034 (USD MILLION/ Units)
        1. Diagnostic Laboratories
        2. Pharmaceutical & Biotechnological Companies
        3. Others
      4. UAE
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      5. Turkey
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      6. Saudi Arabia
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      7. South Africa
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      8. Egypt
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      9. Nigeria
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      10. Rest of MEA
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
    5. LATAM
      1. LATAM India IVD Raw Materials Market By Product 2022-2034 (USD MILLION/ Units)
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
      2. LATAM India IVD Raw Materials Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Molecular Diagnostics
        2. Clinical Chemistry
        3. Immunochemistry
        4. Others
      3. LATAM India IVD Raw Materials Market By End User 2022-2034 (USD MILLION/ Units)
        1. Diagnostic Laboratories
        2. Pharmaceutical & Biotechnological Companies
        3. Others
      4. Brazil
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      5. Mexico
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      6. Argentina
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      7. Chile
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      8. Colombia
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
      9. Rest of LATAM
        1. Antibody
        2. Antigens
        3. Proteins
        4. Enzymes
        5. Biological Buffers
        6. Substrates
        7. Others
        8. Molecular Diagnostics
        9. Clinical Chemistry
        10. Immunochemistry
        11. Others
        12. Diagnostic Laboratories
        13. Pharmaceutical & Biotechnological Companies
        14. Others
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: